Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.
- DOI
- 10.1111/dom.70949
- Published
- 2026 Sep
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.70949,
title = {Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.},
author = {McGill JB and Green JB and Heerspink HJL and Mann JFE and Mottl AK and Rosenstock J and Rossing P and Vaduganathan M and Nangaku M and Brinker M and Scott C and Rohwedder K and Li L and Li N and Seco M and Agarwal R},
year = {2026},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.70949},
url = {https://doi.org/10.1111/dom.70949}
}RIS
TY - JOUR TI - Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial. AU - McGill JB AU - Green JB AU - Heerspink HJL AU - Mann JFE AU - Mottl AK AU - Rosenstock J AU - Rossing P AU - Vaduganathan M AU - Nangaku M AU - Brinker M AU - Scott C AU - Rohwedder K AU - Li L AU - Li N AU - Seco M AU - Agarwal R PY - 2026 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.70949 UR - https://doi.org/10.1111/dom.70949 ER -
APA
JB, M., JB, G., HJL, H., JFE, M., AK, M., J, R., P, R., M, V., M, N., M, B., C, S., K, R., L, L., N, L., M, S., & R, A. (2026). Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70949
Source records
- pubmed · retrieved 2026-09-26T19:04:56.019Z